Background. There is a paucity of data regarding health consequences of Ebola virus disease among survivors. Methods. We surveyed 105 Ebola virus disease survivors postdischarge from an Ebola treatment unit in Guinea using a standard data collection form. Patients rated recovery as the percentage of improvement in functional status, where 0% represents "unable to perform" and 100% represents "able to perform at prior level."
Background. There is a paucity of data regarding health consequences of Ebola virus disease among survivors. Methods. We surveyed 105 Ebola virus disease survivors postdischarge from an Ebola treatment unit in Guinea using a standard data collection form. Patients rated recovery as the percentage of improvement in functional status, where 0% represents "unable to perform" and 100% represents "able to perform at prior level."
Results. The mean ± standard deviation time interval between hospital discharge and administration of questionnaire was 103.5 ± 47.9 days in 105 survivors. Anorexia was reported by 103 patients, with varying severity levels: mild (n = 33), moderate (n = 65), or severe (n = 5). Reported pain according to site was chest (30.7%), joint (86.7%), muscle (26.7%), and back (45.7%), among others. Recovery in functional status was graded as mild (10%-30%) (n = 2 [1.9%]), moderate (40%-70%) (n = 52 [50.0%]), and excellent (80%-100%) (n = 50 [48.1%]). Severity of arthralgia (R 2 = 0.09; P = .008) was directly associated with lower recovery in functional status in multivariate analysis. Conclusions. Ebola virus disease survivors frequently reported anorexia and arthralgia. Severity of arthralgia was related to lower functional recovery. There may be a role for focused screening and intervention for symptoms identified in this study of survivors.
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According to a recent estimate [1] , 23 900 persons have been infected with Ebola virus disease (EVD), with a survival rate of 29.2% in Guinea, Liberia, Nigeria, and Sierra Leone [2] .The survival rate is higher (60%) in patients hospitalized in designated facilities such as Donka National Hospital, Conakry, Guinea [3] . Based on the available data, an estimated 6300-12 600 EVD survivors are residing in West Africa. Our current understanding regarding EVD is based on data collected during acute hospitalization and that reported in small cohorts studied in the Kikwit General Hospital in the 1995 outbreak [2] [3] [4] [5] .Although there is a paucity of data regarding health consequences among EVD survivors, such information is essential for providing posthospitalization care and support for continually increasing numbers of EVD survivors. We performed this study to identify health consequences in EVD survivors using a standard data collection form in Guinea.
METHODS
The Ebola Virus Disease Survivor Study was performed as a joint collaboration between physicians from the United States, Donka National Hospital, and China-Guinea Friendship Hospital, Conakry, Guinea. The study was approved by the Institutional Review Board of Donka National Hospital. The general principles of the protocol conformed to the recommendations of the Declaration of Helsinki developed by the World Medical Association for medical research involving human subjects. Verbal consent was acquired from each of the participants by the interviewing physician who informed the participants regarding the intended objectives of the study.
Study Participants
The survivors were identified from consecutive patients discharged from EVD treatment unit in Donka National Hospital in Conakry, Guinea, which serves as one of the country's designated hospitals for treatment of Ebola virus-infected patients since March 2014 [6] . Ebola virus infection-free status required resolution of symptoms and a negative polymerase chain reaction test prior to discharge. The Ebola isolation unit team maintains contact with all the discharged patients to monitor for recurrence and for identification of volunteers, and of any new cases within the primary residence of the survivor.
An effort was made to contact all the 186 survivors with EVD discharged from Donka National Hospital from 15 March 2014 to 5 August 2014. The questionnaire was administered either through phone or in person by several physicians from participating institutions between 1 November 2014 and 31 January 2015. The questionnaire collected the anonymized data consistent with the recommendations of Privacy Rule (45 C.F.R. § 164.514(b)(2)(i)) and Office of Human Research Protections, United States. The completed questionnaires were scanned and submitted to a central office in the United States and data were entered into a database within Microsoft Excel 2010 (Microsoft Corporation, Redmond, Washington). Data reconciliation was performed in the event of data points that could not be interpreted or missing. A query was sent to the local physician to provide information regarding the variable. In the event the physician was unable to respond to the query, the data were entered as missing. For 10% of the participants, another investigator reviewed the data entry from questionnaire to the database and found a rate of 100% accuracy for data entry.
Development of Questionnaire
The items in the questionnaire were identified based on inperson interviews with medical professionals who were EVD survivors in Conakry, Guinea. Additional input was sought from a member of the Association of Ebola Affected People and Ebola Survivors in Guinea. The questionnaire collected data on demographic variables and time interval elapsed between hospital discharge after EVD-free status and administration of questionnaire. Mechanism of exposure and whether the subject was a healthcare worker were included. The 2 major symptoms identified for quantification were pain and anorexia. We used the numeric pain rating scale to quantify intensity of pain experienced in the last 24 hours [7] because of its good sensitivity for statistical analysis. The numeric pain rating scale is an 11-point scale from 0 (no pain) to 10 (most intense pain imaginable) [8] . The pain was inquired for the following sites: neck, chest, joint, muscle, abdomen, and back. The severity of anorexia was graded according to a 5-point grading scale (none: no symptoms; mild: loss of appetite without alteration in eating habits; moderate: oral intake altered without significant weight loss or malnutrition, oral nutritional supplements indicated; severe: associated with significant weight loss or malnutrition [eg, inadequate oral caloric and/or fluid intake], tube feedings, or parenteral nutrition; and life threatening: disabling, life-threatening consequences, urgent intervention indicated) [9] . We inquired regarding loss of visual acuity based on previous reports [10, 11] . Questions regarding lack of acceptance from family, friends, village, and community were used based on previous reports [10, 11] . Further questions were added regarding confidence and negative impact on social life. We inquired about functional level regained compared with predisease status expressed as a percentage (Patient-Specific Functional Scale) and resumption of premorbid work (occupation) after occurrence of disease. The scale was used because the grades can be used for global functional change compared with other scales that are more task specific [12] . Patients rated their recovery as percentage improvement (in 10% increments) in functional status where 0% represents "unable to perform" and 100% represents "able to perform at prior level." A broader ascertainment was preferred because there were no data available to identify specific functions that should be targeted as a measure of recovery. Resumption of work has been identified by patients of various diseases as an important goal for recovery [13, 14] and measure of effectiveness of recovery from various diseases [15] . Ambulation without difficulty and any abnormalities with urination or defecation were also inquired as indirect measures of recovery [16] . We inquired regarding occurrence of any sleep disturbance, insomnia, or excessive sleepiness.
Statistical Analysis
To identify any response biases, we compared the demographic characteristics of a sample of consecutive EVD survivors (n = 42) discharged from Donka National Hospital from 25 March to 5 August 2014 [3] with those of study participants. Formal sample size estimation was not performed. We estimated that sampling 100 participants would provide us with prevalence estimates of ±10% with 95% probability [17] . Sampling 500 participants would provide us with prevalence estimates of ±5% with 95% probability, but was not considered feasible.
The analysis was predominantly descriptive. Subjects were stratified into 2 groups based on time elapsed between hospital discharge and administration of questionnaire: acute convalescence (0-90 days) and subacute convalescence (91-210 days). The intensity of pain according to pain rating scale was categorized as mild (1-3), moderate (4-6), or severe (7-10) as previously described [18, 19] . The recovery in functional status (compared with preinfection status) was categorized as mild (10%-30%), moderate (40%-70%), or excellent (80%-100%) recovery. We identified any differences in the occurrence and severity of symptoms between acute and subacute convalescence periods using χ 2 for categorical and t test for continuous variables.
We evaluated the correlation between weight change, severity of anorexia, and severity of pain using correlation analysis entering time interval (in days) between hospital discharge and administration of questionnaire as a continuous variable to identify any time-dependent relationship. We performed linear regression analyses, after adjusting for age and sex, to determine the relationship between recovery in functional status (0%-100% in 10% increments) and the following variables: time interval elapsed between hospital discharge and completion of questionnaire, severity of anorexia, and severity of joint pain or arthralgia. The analyses were performed using IBM SPSS statistics software (IBM Corp, Armonk, New York).
RESULTS
Of the 186 identified patients, 105 were available and consented to participate in the study. A total of 81 patients could not be contacted (n = 47) or refused to participate (n = 34). The mean age (±standard deviation [SD]) was significantly higher among those who participated in the survey and those who were among the sample of consecutive EVD survivors discharged from Donka National Hospital (38.9 ± 11.9 vs 31.6 ± 13.9 years; P = .002). No difference in the proportion of men (67.6% vs 54.8%; P = .14) was observed between the 2 groups. The proportion of healthcare workers was significantly higher among those who participated in the study and those who were among the sample of consecutive EVD survivors discharged from Donka National Hospital (29.8% vs 7.1%; P = .004). Among 105 participants, the mean time (±SD) interval between hospital discharge and administration of questionnaire was reported by 89 participants as 103.5 ± 47.9 days. Of the 105 participants, 31 (29.5%) were healthcare professionals, including 14 physicians, 14 nurses, and 3 other professionals. The mean (±SD) loss in self-reported weight of subjects from prediagnosis to time of the questionnaire was 2.9 ± 2.5 kg. Weight loss of ≥5 kg was reported by 12 of 105 participants, with a negative correlation between time interval (in days) between disease-free status and administration of questionnaire (correlation coefficient, −0.59). Anorexia was reported by 103 patients, with severity graded as mild (n = 33), moderate (n = 65), or severe (n = 5). The proportion of participants with moderate or severe anorexia was significantly higher among those in acute convalescence compared with those in subacute convalescence (80.5% vs 60.4%; P = .04). Severity of anorexia was not associated with presence of diarrhea and/or constipation (correlation coefficient of 0.008; P = .93) or mood difference and/or depression (correlation coefficient of −0.030; P = .76). Severity of anorexia demonstrated a negative correlation between time interval (in days) between hospital discharge and administration of questionnaire (correlation coefficient, −0.195). Most participants reported joint pain (86.7%) and back pain (45.7%) ( Table 1 ). The pain severity of arthralgia was not reported by 7 participants who responded "yes" to arthralgia. Severity of arthralgia demonstrated a negative correlation between time interval (in days) between disease-free status and administration of questionnaire (correlation coefficient, −0.16).
The frequency of symptoms according to body system and acute and subacute convalescence period is presented in Table 1 . A total of 100 participants (96.2%) reported returning to previous work, with a higher rate of return to previous work in participants in subacute convalescence compared with acute convalescence (97.9% vs 92.7%; P = .24). All the patients in whom time interval between hospital discharge and administration of questionnaire was ≥160 days had returned to work. Of the 105 participants, 104 provided information on percentage recovery in functional status at the time of administration of questionnaire. One patient of 104 (1%) participants reported complete recovery (score of 100%). The recovery was graded as mild (n = 2 [1.9%]), moderate (n = 52 [50.0%]), and excellent (n = 50 [48.1%]). There was no difference in the rate of excellent recovery in participants in subacute convalescence compared with acute convalescence (52.1% vs 52.5%; P = .97). The relationship between time interval elapsed between hospital discharge and completion of questionnaire and percentage recovery in functional status after adjusting for age and sex was not significant (R 2 = 0.023; P = .18). There was a direct relationship between severity of arthralgia (10-point scale) and percentage recovery in functional status after adjusting for age and sex (R 2 = 0.09; P = .008). There was a significant inverse relationship between severity of anorexia grades (5-point scale) and percentage of recovery in functional status after adjusting for age and sex (R 2 = 0.05; P = .04).
DISCUSSION
We present data regarding physical and psychological symptoms experienced by EVD survivors that characterize the post-EVD syndrome. Anorexia and chronic pain, particularly in joints and muscles, were frequently reported by survivors.
Other symptoms such as difficulty in short-term memory, headaches, sleep difficulties, insomnia, dizziness, abdominal pain, constipation, decreased exercise tolerance, decreased libido, and sexual dysfunction were also reported. Prominent psychiatric symptoms including change in level of self-confidence and frequent experiencing of social rejection were reported. Approximately 50% of the survivors reported that they had recovered to ≤70% of their premorbid functional status. There was a relationship between severity of arthralgia and percentage recovery in functional status. A very high proportion of participants reported returning to their previous jobs despite less than optimal functional recovery, which may be in part related to financial pressures. An important issue is whether the symptomatology experienced by EVD survivors is a postinfectious syndrome seen with other viral illnesses [20] or a somatic manifestation of psychiatric illnesses such as depression and anxiety [21] . Certain symptoms such as arthralgia, myalgia, headache, anorexia, and weight loss are seen in the acute period of EVD [2] [3] [4] [5] and may be a continuation of the symptomatology in the face of slow recovery. Disseminated intravascular coagulation and elevated circulating D-dimers have been reported with EVD [22] [23] [24] and may play a role in pathogenesis of arthralgias. Late osteoarticular lesions have been described after disseminated intravascular coagulation associated with other infections [25] . Although we did not collect data pertaining to acute-phase coagulopathy, hemorrhagic manifestations, and fibrinogenolysis among the survivors, hemorrhagic events were infrequent in the current EVD outbreak and unlikely to have played a major role in occurrence of arthralgias. In a previous study [3] , any hemorrhagic event was only seen in 13 of 70 patients during acute hospitalization among patients admitted to Donka National Hospital. Several proinflammatory cytokines such as tumor necrosis factor, interleukin 1α, interleukin 6, interferon γ-inducible protein, monocyte chemoattractant protein, and macrophage colony-stimulating factor are elevated in acute EVD [23, 26] . However, there are very low levels of circulating cytokines produced by T lymphocytes and widespread apoptosis of peripheral CD4 and CD8 lymphocytes [27] . Persistent elevations of proinflammatory cytokines and immune dysregulation have been implicated in the other postviral myalgias and arthralgias [28, 29] . Synergistic and antagonistic interactions between various cytokines and neurochemicals are implicated in the pathogenesis of anorexia [30] . In our analysis, we did not observe a relationship between severity of anorexia and other gastrointestinal symptoms or mood disturbances and/or depression, which would be consistent with the abovementioned pathogenic process. Abnormalities in fiber density [31] , excitability of muscles [32] , and muscle metabolism; regional cerebral blood flow alterations in the brain stem and hypothalamic-pituitary-adrenal axis; and demyelination in the reticular activating system have been implicated in fatigue and sleep abnormalities observed in the postviral infection period [33] [34] [35] . It should be noted that none of the above-mentioned pathologic findings have been studied or documented in survivors of EVD as of yet.
A study of 60 survivors of the 1995 EVD outbreak in Kikwit, Democratic Republic of Congo, was previously reported [13] . Of the 60 survivors, only 34 (57%) participated, with 7% and 25% of the survivors either refusing to participate or not being traceable, respectively. In our study, the 42% rate of nonparticipation was similar to the rate reported in the previous study [13] , predominantly attributed to lack of traceability after discharge. During convalescence, 12 (35%) felt rejected by family, friends, and neighbors and 32% considered the event as divine punishment [13] . Twenty of the 71 EVD survivors enrolled in another 3-month follow-up study [11] . Of these 20 survivors, 3 patients complained of ocular pain, photophobia, hyperlacrimation, and loss of visual acuity. Other physical symptoms were not inquired in either study. Bwaka et al [36] reported on 19 EVD survivors in 1995, assessed between 2 weeks and 2 months after hospitalization, and noted that 7 of the 19 patients had arthralgia and 2 patients had hearing loss or tinnitus. In our study, none of the survivors reported hearing or vision loss. Some of the differences in symptomatology experienced by EVD survivors in the current outbreak between the 2 studies may be attributed to differences in initial manifestations. The prominently higher rate of hemorrhagic manifestations, myalgias, arthralgias, and anorexia during acute illness in 1995 EVD outbreak should be noted [3, 37] compared with the current outbreak in Guinea. Our study also provides an in-depth analysis of arthralgia, weight loss, and anorexia among EVD survivors over a much larger spectrum of time intervals from hospital discharge.
In the absence of previous information, we relied on input from healthcare survivors to identify the items to be included in the questionnaire. The use of specific definitions and quantification scales was avoided for many items due to pragmatic reasons based on restricted resources and the voluntary nature of the project. There may be undefined biases in ability to contact the survivors, with easier access to persons who returned to their jobs. We noticed that there was an overrepresentation of medical professionals in the sample who responded compared with a sample of survivors discharged from Donka National Hospital. The possibility that survivors who had more severe symptoms subsequent to EVD were residing with family in distant villages and were not approachable cannot be excluded. The relatively small sample size reduces the precision of estimates reported in our analysis. There are interobserver variations in self-rating of functional status [38] , and the impact of such variations on our findings is not known. Despite the limitations, our report identifies several aspects of the spectrum of post-EVD syndrome.
Our findings highlight the need for continued surveillance among survivors of EVD. In countries where psychiatric and psychological care may be limited, provision of such care may require additional resources and awareness. There may be a role for focused screening and intervention for the symptoms identified in our study among survivors of EVD.
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